HKRH homeAbout UsOur BusinessInvestor RelationsMediaStock InformationContact Us
 
Company Overview
Corporate Structure
Board of Directors & Senior Management
Mission Statement
Corporate Governance
  Home > About Us > Board of Directors & Senior Management
Board of Directors & Senior Management
EXECUTIVE DIRECTORS
Mr. LAM Kwok Hing, Wilfred

Mr. Lam Kwok Hing, Wilfred, J.P., aged 59, was appointed as an Executive Director and Group Vice President on 17 August 2011, re-designated as a Non-executive Director on 1 July 2015 and then re-designated again as an Executive Director on 12 April 2017. Mr. Lam holds a bachelor degree in Law with honours from the University of Hong Kong.

Mr. Lam is the chairman and executive director of Chinese Strategic Holdings Limited (Stock Code: 8089). Mr. Lam was the non-executive director of The Hong Kong Building and Loan Agency Limited (Stock Code: 145) from 21 October 2011 to 21 October 2017.  Mr. Lam was the chairman and executive director of Lamtex Holdings Limited (formerly known as China New Energy Power Group Limited) (Stock Code: 1041) from 16 June 2015 to 13 March 2016. Mr. Lam was an independent non-executive director of PME Group Limited (Stock Code: 379) from 14 April 2011 to 30 December 2014. Mr. Lam was a director (appointed as an independent non-executive director on 13 May 2009, re-designated to a non-executive director on 3 February 2010, appointed as a non-executive vice-chairman on 5 August 2010 and resigned on 11 July 2014) of National Arts Entertainment and Culture Group Limited (Stock Code: 8228) from 13 May 2009 to 11 July 2014. Mr. Lam was an independent non- executive director of Value Convergence Holdings Limited (Stock Code: 821) from 4 January 2010 to 30 May 2013. All of these companies are listed on the Stock Exchange of Hong Kong Limited (the “Stock Exchange”).


Mr. Xu Zhigang

Mr. Xu Zhigang, aged 47, was appointed as an Executive Director and chief executive officer on 14 February 2018.  Mr. Xu holds a master’s degree in business management from Southwest Jiaotong University in the PRC. Mr. Xu was the chairman and an executive director of Prosten Health Holdings Limited (stock code: 8026) up to 12 February 2018 and was then re-designated to a nonexecutive director. Mr. Xu was a vice president of Kaisa Health Group Holdings Limited (formerly known as “Mega Medical Technology Limited”, “Wing Tai Investment Holdings Limited” and “Wing Lee Holdings Limited”) (stock code: 876) and an executive director and later re-designated as a nonexecutive director of Aurum Pacific (China) Group Limited (stock code: 8148). All of these companies are listed on the Stock Exchange of Hong Kong Limited (the “Stock Exchange”). Mr. Xu has extensive experience in areas such as corporate management, business financing, corporate investment and asset acquisition.


Mr. Zhao Jianguo

Mr. Zhao Jianguo, aged 38, was appointed as an Executive Director on 31 May 2017. Mr. Zhao holds a bachelor degree in civil engineering from Shijiazhuang Railway Institute and a master degree in finance from University of International Business and Economics, China. Mr. Zhao worked for China Minmetals Corporation from 2006 to 2016, and has served as the manager of planning department and investment department of China National Metal Products Co., Ltd. and, from 2013 to 2016, the deputy general  manager of China National Metal Hong Kong Corporation Limited. Mr. Zhao is currently the general manager of equity investment department and the deputy general manager of Kerui Jinrong Limited.


Ms. Dai Wei

Ms. Dai Wei, aged 38, was appointed as an Executive Director on 31 May 2017. Ms. Dai holds a double master degree in Financial and Acturial Engineering from Katholic University of Leuven, Belgium. Ms. Dai has worked for ING Bank and China Sonangol International Limited. Ms. Dai was the chief financial officer of Titan Petrochemicals Group Limited (stock code: 1192), a company listed on the main board of the Stock Exchange. Ms. Dai has been assigned key positions in a number of cross border merger and acquisition and investment projects in gas, oil and mining.


    INDEPENDENT NON-EXECUTIVE DIRECTORS
   
Dr. Loke Yu alias Loke Hoi Lam

Dr. Loke Yu alias Loke Hoi Lam, aged 69, was appointed as an Independent Non-executive Director on 31 May 2017. Dr. Loke has over 40 years of experience in accounting and auditing for private and public companies, financial consultancy and corporate management. He holds a master of business administration degree from Universiti Teknologi Malaysia and a doctor of business administration degree from University of South Australia. Dr. Loke is a fellow member of The Institute of Chartered Accountants in England & Wales, The Hong Kong Institute of Certified Public Accountants, The Hong Kong Institute of Chartered Secretaries and Hong Kong Independent Non-Executive Directors Association.

Dr. Loke` and serves as an independent non-executive director of V1 Group Limited (stock code: 82), China Beidahuang Industry Group Holdings Limited (stock code: 39), CIMC-TianDa Holdings Company Limited (stock code: 445), Matrix Holdings Limited (stock code 1005), SCUD Group Limited (stock code 1399), Zhong An Real Estate Limited (stock code 672), Chiho Environment Group Limited (stock code 976), Tianjin Development Holdings Limited (stock code 882), China Household Holdings Limited (stock code 692), Tianhe Chemicals Group Limited (stock code 1619), Lamtex Holdings Limited (stock code 1041), Forebase International Holdings Limited (stock code: 2310), Hang Sang (Siu Po) International Holding Company Limited (stock code 3626), Zhenro Properties Group Limited and TC Orient Lighting Holdings Limited (stock code  0515).  He was an independent non-executive director of Mega Medical Technology Limited (stock code: 876) from 20 June 2014 to 10 January 2017 and Winfair Investment Company Limited (stock code 287) from 2 April 2007 to 2 April 2018.  All of these companies are listed on the main board of the Stock Exchange.


Mr. Xu Xiaoping

Mr. Xu Xiaoping, aged 53, was appointed as an Independent Non-executive Director on 31 May 2017. Mr. Xu is an experienced management personnel. Mr. Xu started his career in 1989 and has served in 深華貿易有限公司 (Shen Hua Trading Limited) and 天奇電子有限公司 (Tian Qi Electrons Limited), which were companies carrying on the business of online banking services in the PRC. Mr. Xu has also acted as the chairman of the board of directors of 深圳市奔翔物流有限公司 (Shenzhen Ben Xiang Logistics Limited), a company carrying on the business of air cargo services in the PRC. Mr. Xu is currently the investor of 嘉興友夲投資合夥企業 (Jia Xing You Ben Investment Partnership), which is engaged in the venture capital business. Mr. Xu is an independent non-executive director of Prosten Health Holdings Limited (stock code: 8026), a company listed on the Growth Enterprise Market of the Stock Exchange. He was a non- executive director of PPS International (Holdings) Limited (stock code: 8201), a company listed on the Growth Enterprise Market of the Stock Exchange, from 22 October 2015 to 3 July 2016.


Mr. Fan, Anthony Ren Da

Mr. Fan, Anthony Ren Da, aged 58, was appointed as an Independent Non-executive Director on 30 September 2008. Mr. Fan holds a master degree of business administration from the United States. He is the chairman and managing director of AsiaLink Capital Limited. Prior to that, he held senior positions with various international financial institutions and was the managing director of a company listed on the Stock Exchange.


     
     
    Back to top
 
     
Retail BusinessTrading of Precious Metal and Electroplating Chemicals
3D-Gold3D-Gold ManagementGold SaltSilver Salt
Jewellery DesignRetail NetworkPalladium SaltRhodium Salt